CD164 and neoplasm: We found that CD164 was uniformly expressed at the mRNA level on CD26− and CD26+ cells, but the protein was only detectable on the surface of specific subsets of cells, with the percentages of CD26−CD164+ cells increasing with increasing tumor burden.